Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00106496 · ClinicalTrials.gov registry record · Phase 4
A Multi-Center Study of Short and Long-term Use of Protopic Ointment in Patients With Atopic Dermatitis
A Phase 4 study, sponsored by Astellas Pharma.
- Completed
- Registry status
- Phase 4
- Development phase
- 410
- Enrollment target
NCT00106496 is a Phase 4 study that has completed, run by Astellas Pharma. The registered enrollment target is 410 participants.
The verdict
NCT00106496, a Phase 4 study, has completed, sponsored by Astellas Pharma.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 410 participants
- Enrollment target
Study Summary
The purpose of the study is to determine the impact of topical corticosteroids on the safety and effectiveness of Protopic Ointment in the short-term treatment of moderate to severe Atopic Dermatitis and to compare the safety and effectiveness of Protopic Ointment to placebo in the long-term management of Atopic Dermatitis
Interventions
- DRUG placebo
- DRUG Corticosteroid
- DRUG Protopic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 410 participants |
| Start Date | 2004-10 |
| Est. Completion | 2006-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00106496
The ClinicalTrials.gov registry entry for NCT00106496 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 410 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Astellas Pharma, which has 165 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which placebo is the first listed.
NCT00106496 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00106496 about?
NCT00106496 is a clinical study titled "A Multi-Center Study of Short and Long-term Use of Protopic Ointment in Patients With Atopic Dermatitis". The purpose of the study is to determine the impact of topical corticosteroids on the safety and effectiveness of Protopic Ointment in the short-term treatment of moderate to severe Atopic Dermatitis and to compare the safety and effectiveness of Protopic Ointment to placebo in the long-term managem...
What is the current status of trial NCT00106496?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 410 participants. The study started on 2004-10. Estimated completion is 2006-07.
What interventions are being tested in trial NCT00106496?
The interventions under investigation include: placebo (DRUG), Corticosteroid (DRUG), Protopic (DRUG).
Who is sponsoring clinical trial NCT00106496?
This trial is sponsored by Astellas Pharma, which has 165 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.